6533b85efe1ef96bd12bfdf4

RESEARCH PRODUCT

Prevention of Rat Intestinal Injury with a Drug Combination of Melatonin and Misoprostol

David DahlgrenHans LennernäsAlkwin WandersPer M. HellströmMaria-jose Cano-cebriánMarkus Sjöblom

subject

Malemedicine.medical_treatmentsingle-pass intestinal perfusionPharmacologylcsh:Chemistrychemistry.chemical_compoundPharmaceutical SciencesPharmaceutical sciencesSodium dodecyl sulfateIntestinal MucosaMisoprostollcsh:QH301-705.5Spectroscopymedia_commonMelatoninSodium Dodecyl SulfateGeneral MedicineAbsorció intestinalComputer Science ApplicationsIntestinesPerfusionDrug CombinationsSingle-pass intestinal perfusionPhenobarbitalgastrointestinal physiologyMisoprostolmedicine.drugDrugFarmacologiamedia_common.quotation_subjectGastroenterology and HepatologyIntestinal permeabilityCatalysisPermeabilityArticleInorganic ChemistryMelatoninmedicineGastroenterologiAnimalsPhysical and Theoretical ChemistryRats WistarMolecular BiologyEdetic AcidChemotherapyIntestinal permeabilityGastrointestinal Physiologybusiness.industryintestinal permeabilityOrganic Chemistrymedicine.diseaseFarmaceutiska vetenskaperRatsIntestinal Diseaseschemistrylcsh:Biology (General)lcsh:QD1-999Intestinal barrier dysfunctionGastrointestinal physiologybusinessintestinal barrier dysfunction

description

A healthy intestinal barrier prevents uptake of allergens and toxins, whereas intestinal permeability increases following chemotherapy and in many gastrointestinal and systemic diseases and disorders. Currently, there are no approved drugs that target and repair the intestinal epithelial barrier while there is a medical need for such treatment in gastrointestinal and related conditions. The objective of this single-pass intestinal perfusion study in rats was to investigate the preventive cytoprotective effect of three mucosal protective drugs&mdash

10.3390/ijms21186771https://www.mdpi.com/1422-0067/21/18/6771